Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid

EU orphan designation number: EU/3/01/079   
Active ingredient: Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid
Indication: Treatment of acute lung injury
Sponsor: Pharm Research Associates (UK) Limited
Pacific House, Imperial Way, Reading, Berkshire RG2 0TD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/02/2002 Centralised Orphan - Designation EMEA/OD/008/01 (2002)467 of 04/02/2002
08/05/2007 Other procedure
30/09/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/008/01/T/01 (2010)6799 of 28/09/2010